• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN CRM S.A.S SYMPHONY; PULSE GENERATOR, PERMANENT, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN CRM S.A.S SYMPHONY; PULSE GENERATOR, PERMANENT, IMPLANTABLE Back to Search Results
Model Number RHAPSODY + DR 2530
Device Problem Pacing Problem (1439)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/07/2020
Event Type  Injury  
Event Description
Reportedly, during a follow-up performed on (b)(6) 2020, it was observed that the battery impedance was 6.43kohms and the estimated residual longevity was 15 months.A pacemaker replacement procedure was then scheduled.It was confirmed during pre-procedure checks that the atrial and ventricular leads were programmed in bipolar pacing and sensing configurations.The device was left programmed in vvi mode, 30min-1 prior to the procedure.After the device was removed from the chest, long ventricular pauses were observed due to loss of pacing output, despite the fact that the ventricular lead was connected to the pacemaker and the pacemaker can was not being manipulated.The ventricular lead was connected to a pacing system analyzer (psa) and pacing output was regained.Normal ventricular lead impedance was measured and no evidence of noise oversensing on the ventricular channel was observed.No anomaly was observed during lead tests that were performed after the leads were connected to the newly implanted device.The patient was pacemaker-dependant.Preliminary analysis results showed that based on available data, normal battery depletion occurred based on hrs guidelines.
 
Event Description
Reportedly, during a follow-up performed on (b)(6) 2020, it was observed that the battery impedance was 6.43kohms and the estimated residual longevity was 15 months.A pacemaker replacement procedure was then scheduled.It was confirmed during pre-procedure checks that the atrial and ventricular leads were programmed in bipolar pacing and sensing configurations.The device was left programmed in vvi mode, 30min-1 prior to the procedure.After the device was removed from the chest, long ventricular pauses were observed due to loss of pacing output, despite the fact that the ventricular lead was connected to the pacemaker and the pacemaker can was not being manipulated.The ventricular lead was connected to a pacing system analyzer (psa) and pacing output was regained.Normal ventricular lead impedance was measured and no evidence of noise oversensing on the ventricular channel was observed.No anomaly was observed during lead tests that were performed after the leads were connected to the newly implanted device.The patient was pacemaker-dependant.Preliminary analysis results showed that based on available data, normal battery depletion occurred based on hrs guidelines.
 
Manufacturer Narrative
Electrical and mechanical characteristics of the returned device were within specifications.
 
Event Description
Reportedly, during a follow-up performed on (b)(6) 2020, it was observed that the battery impedance was 6.43kohms and the estimated residual longevity was 15 months.A pacemaker replacement procedure was then scheduled.It was confirmed during pre-procedure checks that the atrial and ventricular leads were programmed in bipolar pacing and sensing configurations.The device was left programmed in vvi mode, 30min-1 prior to the procedure.After the device was removed from the chest, long ventricular pauses were observed due to loss of pacing output, despite the fact that the ventricular lead was connected to the pacemaker and the pacemaker can was not being manipulated.The ventricular lead was connected to a pacing system analyzer (psa) and pacing output was regained.Normal ventricular lead impedance was measured and no evidence of noise oversensing on the ventricular channel was observed.No anomaly was observed during lead tests that were performed after the leads were connected to the newly implanted device.The patient was pacemaker-dependant.Preliminary analysis results showed that based on available data, normal battery depletion occurred based on hrs guidelines.
 
Manufacturer Narrative
Please refer to the attached analysis report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYMPHONY
Type of Device
PULSE GENERATOR, PERMANENT, IMPLANTABLE
Manufacturer (Section D)
SORIN CRM S.A.S
98 rue maurice arnoux
.
montrouge, 92120
FR  92120
MDR Report Key11123262
MDR Text Key225299448
Report Number1000165971-2021-00209
Device Sequence Number1
Product Code NVZ
Combination Product (y/n)N
PMA/PMN Number
P950029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 06/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/11/2008
Device Model NumberRHAPSODY + DR 2530
Device Catalogue NumberRHAPSODY + DR 2530
Device Lot NumberS060926
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/06/2021
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/17/2020
Event Location Hospital
Initial Date Manufacturer Received 12/17/2020
Initial Date FDA Received01/06/2021
Supplement Dates Manufacturer Received01/12/2021
05/07/2021
Supplement Dates FDA Received02/04/2021
06/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-